SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-002209
Filing Date
2020-02-13
Accepted
2020-02-13 15:24:58
Documents
80
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1886376
2 ex10-13.htm EX-10.13 77536
3 ex10-14.htm EX-10.14 49520
4 ex10-15.htm EX-10.15 84996
5 ex10-16.htm EX-10.16 70590
6 ex31-1.htm EX-31.1 11664
7 ex31-2.htm EX-31.2 11681
8 ex32-1.htm EX-32.1 6420
9 ex32-2.htm EX-32.2 6405
10 form10-q_001.jpg GRAPHIC 7173
  Complete submission text file 0001493152-20-002209.txt   8632942

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE taug-20191231.xml EX-101.INS 1387662
12 XBRL SCHEMA FILE taug-20191231.xsd EX-101.SCH 76548
13 XBRL CALCULATION FILE taug-20191231_cal.xml EX-101.CAL 70361
14 XBRL DEFINITION FILE taug-20191231_def.xml EX-101.DEF 325427
15 XBRL LABEL FILE taug-20191231_lab.xml EX-101.LAB 533996
16 XBRL PRESENTATION FILE taug-20191231_pre.xml EX-101.PRE 426181
Mailing Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022
Business Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53723 | Film No.: 20609901
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences